In a study of 215 bone marrow samples from CBF-AML by high-throughput sequencing, high NRAS:KRAS mutant allele ratios were associated with the absence of KIT or FLT3 mutations and a favorable outcome [92]. This evidence concerns the gene FLT3 and acute myeloid leukemia.